These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2004-001290-25||A 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing de Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (...||2011-12-31||bad-data|
|Ongoing||2004-004691-37||Etanercept in Psoriasis and Psoriatic Arthritis: a single center, open-label study in 15 patients.||not-yet-due|
|Ongoing||2006-006692-20||The TOMIBA study||not-yet-due|
|Not reported||2009-017525-19||Abatacept in Psoriasis and Psoriatic Arthritis:||2014-08-11||due-trials|
|Ongoing||2011-002561-38||A double blind, randomized, placebo controlled, crossover study of the effectiveness of oral fampridine in improving upper limb function in progressive multiple sclerosis.||not-yet-due|
|Ongoing||2016-001785-29||Combined Effect of CFTR Modifiers and Intensive Antibiotic Treatment||not-yet-due|